GLI Spearheads Initiative to Double the Five-Year Survival Rate by 2030
Washington, DC — The Global Liver Institute (GLI), along with 33 other leading health and medical organizations, has issued a global call-to-action to increase the five-year survival rate for liver cancer from 18% to 36% by 2030.
Liver cancer is a leading cause of cancer deaths worldwide, accounting for more than 700,000 deaths each year. In the United States this year alone more than 42,000 people will be diagnosed with liver cancer and more than 31,000 people will die from this disease. The National Cancer Institute estimates that there were more than 83,000 people living with liver cancer in the United States in 2016.
To read the full press release click here.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More